GFM
AUPH icon

GF Fund Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

GF Fund Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8K Sell
2,815
-132
-4% -$2.11K ﹤0.01% 393
2026
Q1 		$43.7K Buy
2,947
+357
+14% +$5.22K ﹤0.01% 416
2025
Q4 		$41.3K Sell
2,590
-242
-9% -$3.43K ﹤0.01% 422
2025
Q3 		$31.3K Sell
2,832
-834
-23% -$9.11K ﹤0.01% 439
2025
Q2 		$31.1K Hold
3,666
– – ﹤0.01% 457
2025
Q1 		$29.5K Buy
3,666
+660
+22% +$5.35K ﹤0.01% 462
2024
Q4 		$27K Buy
+3,006
New +$24.5K ﹤0.01% 445

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's AUPH Position: Q2 2026 in Review

GF Fund Management reduced its Aurinia Pharmaceuticals (AUPH) stake by 4.5% in Q2 2026, selling an estimated $2.11K and leaving 2,815 shares worth $47.8K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

GF Fund Management first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • GF Fund Management held 2,815 shares of Aurinia Pharmaceuticals worth $47.8K as of Q2 2026.
  • GF Fund Management sold 132 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $2.11K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #393 holding.
  • GF Fund Management first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.